☰

Neal R. Swerdlow - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
neuropsychiatry
Website:
http://psychiatry.ucsd.edu/swerdlow/index.html
Tree Info Grants Similar researchers PubMed Report error

279/401 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophrenia Bulletin. PMID 32856089 DOI: 10.1093/Schbul/Sbaa116  0.377
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32830097 DOI: 10.1016/J.Bpsc.2020.05.011  0.372
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32829382 DOI: 10.1038/S41386-020-00806-5  0.373
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/Journal.Pone.0232855  0.343
2020 Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32340927 DOI: 10.1016/J.Bpsc.2020.02.004  0.404
2020 Young JW, Roberts BZ, Breier M, Swerdlow NR. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Psychopharmacology. PMID 32318751 DOI: 10.1007/S00213-020-05511-1  0.386
2020 Kotz J, Talledo J, Bhakta S, Roberts B, Light G, Swerdlow N. Amphetamine Enhances Learning in Schizophrenia Patients: Relationship to Baseline Motivational and Neurocognitive Deficits Biological Psychiatry. 87: S362. DOI: 10.1016/j.biopsych.2020.02.928  0.383
2020 Joshi Y, Michael T, Molina J, MacDonald L, Nungaray J, Cardoso L, Sprock J, Braff D, Green M, Nuechterlein K, Stone W, Gur R, Gur R, Swerdlow N, Light G. Impact of Anticholinergic Medication Burden on Cognition in Schizophrenia in the Consortium on the Genetics of Schizophrenia (COGS-2) Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1029  0.367
2019 Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophrenia Research. PMID 31759809 DOI: 10.1016/J.Schres.2019.11.015  0.342
2019 Hochberger WC, Thomas ML, Joshi YB, Swerdlow NR, Braff DL, Gur RE, Gur RC, Light GA. Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning. Schizophrenia Research. PMID 31744751 DOI: 10.1016/J.Schres.2019.10.011  0.317
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/Jamapsychiatry.2019.2850  0.379
2019 Swerdlow NR. Commentary: Lessons Learned From Animal Models for Schizophrenia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31542196 DOI: 10.1016/j.jagp.2019.08.019  0.339
2019 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31445502 DOI: 10.1038/S41386-019-0495-4  0.402
2019 Lainscsek C, Sampson AL, Kim R, Thomas ML, Man K, Lainscsek X, Swerdlow NR, Braff DL, Sejnowski TJ, Light GA. Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 116: 3847-3852. PMID 30808768 DOI: 10.1073/Pnas.1810572116  0.319
2019 Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research. PMID 30738698 DOI: 10.1016/J.Schres.2019.01.016  0.301
2018 Hochberger WC, Joshi YB, Zhang W, Thomas ML, Braff DL, Swerdlow NR, Light GA. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 30586570 DOI: 10.1016/J.Ijpsycho.2018.12.014  0.369
2018 Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30377381 DOI: 10.1038/S41386-018-0256-9  0.347
2018 Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, et al. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research. PMID 30055883 DOI: 10.1016/J.Schres.2018.07.025  0.344
2018 Kantrowitz JT, Swerdlow NR, Dunn W, Vinogradov S. Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29656951 DOI: 10.1016/j.bpsc.2018.02.002  0.36
2018 Swerdlow NR, Bhakta SG, Light GA. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophrenia Research. PMID 29627173 DOI: 10.1016/J.Schres.2018.03.037  0.362
2018 Swerdlow NR, Light GA. Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophrenia Research. PMID 29525460 DOI: 10.1016/J.Schres.2018.02.042  0.367
2018 Joshi Y, Thomas M, Bismark A, Treichler E, Tarasenko M, Cardoso L, Nungaray J, Molina J, Tiernan K, Swerdlow N, Light G. T207. Schizophrenia Patients in Community-Based Residential Care are Able to Benefit From Auditory-Based Targeted Cognitive Training: Improvement in Cognitive Measures and Positive Symptoms Biological Psychiatry. 83: S208-S209. DOI: 10.1016/J.Biopsych.2018.02.544  0.306
2018 Greenwood T, Lazzeroni L, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light G, Nuechterlein K, Olincy A, Radant A, Seidman L, Siever L, Silverman J, Stone W, ... ... Swerdlow N, et al. S209. Genome-Wide Association of Endophenotypes for Schizophrenia From the Consortium On the Genetics of Schizophrenia (COGS) Study Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1101  0.356
2018 Swerdlow N, Bhakta S, Talledo J, Franz D, Rana B, Light G. 72. One Pill Can Enhance Auditory Information Processing and Learning in Schizophrenia Patients: Should We Rethink the Way We’re Approaching Therapeutic Development for Schizophrenia? Biological Psychiatry. 83: S29-S30. DOI: 10.1016/J.Biopsych.2018.02.089  0.368
2017 Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29154367 DOI: 10.1038/Npp.2017.285  0.43
2017 Bhakta SG, Light GA, Talledo JA, Balvaneda B, Hughes E, Alvarez A, Rana BK, Young JW, Swerdlow NR. Tolcapone-enhanced neurocognition in healthy adults: neural basis and predictors. The International Journal of Neuropsychopharmacology. PMID 29020372 DOI: 10.1093/Ijnp/Pyx074  0.305
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/J.Schres.2017.05.013  0.38
2017 Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425497 DOI: 10.1038/Npp.2017.81  0.381
2017 Tarasenko M, Zhang W, Shiluk A, Rackelmann S, Taylor A, Cardoso L, Bismark A, Thomas M, Sprock J, Tiernan K, Kauffman C, Swerdlow N, Light G. SA62. The Auditory Brainstem Response to Complex Sounds (cABR) Indexes Cognitive Network Function in Schizophrenia Schizophrenia Bulletin. 43: S135-S135. DOI: 10.1093/Schbul/Sbx023.061  0.303
2017 Swerdlow N, Bhakta S, Thomas M, Joshi Y, Zhang W, Talledo J, Light G. 124. Experimental Medicine Approaches to Leveraging Auditory Information Processing Neuroplasticity Toward Therapeutic Development in Schizophrenia Schizophrenia Bulletin. 43: S69-S69. DOI: 10.1093/Schbul/Sbx021.182  0.336
2017 Swerdlow N, Bhakta S, Thomas M, Joshi Y, Zhang W, Talledo J, Light G. 430. Leveraging Auditory Information Processing Neuroplasticity towards Therapeutic Development in Schizophrenia Biological Psychiatry. 81: S175-S176. DOI: 10.1016/J.Biopsych.2017.02.914  0.35
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, ... ... Swerdlow NR, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.368
2016 Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophrenia Bulletin. PMID 27798224 DOI: 10.1093/Schbul/Sbw148  0.388
2016 Swerdlow NR, Light GA. Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant? Current Topics in Behavioral Neurosciences. PMID 27311762 DOI: 10.1007/7854_2015_5012  0.399
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, ... ... Swerdlow NR, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.364
2016 Powell SB, Swerdlow NR. Social Isolation Rearing and Sensorimotor Gating in Rat Models of Relevance to Schizophrenia: What We Know, and What We Do Not Know Handbook of Behavioral Neuroscience. 23: 125-138. DOI: 10.1016/B978-0-12-800981-9.00009-2  0.417
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, ... ... Swerdlow NR, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/J.Schres.2015.11.008  0.35
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/Appi.Ajp.2015.15050605  0.323
2015 Amitai N, Powell S, Weber M, Swerdlow NR, Young JW. Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cognitive, Affective & Behavioral Neuroscience. PMID 26220402 DOI: 10.3758/S13415-015-0369-0  0.338
2015 Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. Memantine Effects on Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26062785 DOI: 10.1038/Npp.2015.162  0.388
2015 Light GA, Swerdlow NR. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Annals of the New York Academy of Sciences. 1344: 105-19. PMID 25752648 DOI: 10.1111/Nyas.12730  0.343
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, ... Swerdlow NR, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.391
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, ... ... Swerdlow NR, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.369
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, ... ... Swerdlow NR, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.388
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, ... ... Swerdlow NR, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/J.Schres.2014.10.029  0.325
2015 Swerdlow NR, Gur RE, Braff DL. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research. Schizophrenia Research. 163: 9-16. PMID 25454799 DOI: 10.1016/j.schres.2014.09.047  0.371
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/J.Schres.2014.09.042  0.354
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, ... ... Swerdlow NR, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/J.Schres.2014.10.049  0.336
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, ... ... Swerdlow NR, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/J.Schres.2014.09.024  0.36
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, ... ... Swerdlow NR, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/J.Schres.2014.08.014  0.355
2014 Tarasenko MA, Swerdlow NR, Makeig S, Braff DL, Light GA. The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis. Frontiers in Psychiatry. 5: 142. PMID 25352811 DOI: 10.3389/Fpsyt.2014.00142  0.324
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/J.Psychres.2014.05.035  0.349
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/Schbul/Sbu064  0.333
2014 Light GA, Swerdlow NR. Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle. Current Topics in Behavioral Neurosciences. 21: 293-314. PMID 24850080 DOI: 10.1007/7854_2014_316  0.363
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, ... ... Swerdlow N, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.373
2014 Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophrenia Research. 152: 503-12. PMID 24405980 DOI: 10.1016/J.Schres.2013.12.004  0.406
2014 Perez VB, Swerdlow NR, Braff DL, Näätänen R, Light GA. Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomarkers in Medicine. 8: 9-14. PMID 24325220 DOI: 10.2217/Bmm.13.133  0.322
2013 Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behavioural Brain Research. 257: 118-28. PMID 24076151 DOI: 10.1016/J.Bbr.2013.09.005  0.387
2013 Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 154: 518-29. PMID 23911319 DOI: 10.1016/J.Cell.2013.06.049  0.344
2013 Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA. Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. Neuropharmacology. 75: 38-46. PMID 23810830 DOI: 10.1016/J.Neuropharm.2013.06.003  0.434
2013 Swerdlow NR, Hines SR, Herrera SD, Weber M, Breier MR. Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains. Pharmacology, Biochemistry, and Behavior. 106: 128-31. PMID 23567203 DOI: 10.1016/j.pbb.2013.03.015  0.437
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/Appi.Ajp.2012.12020186  0.326
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, ... Swerdlow NR, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/J.Biopsych.2012.12.021  0.358
2013 Chou HH, Talledo JA, Lamb SN, Thompson WK, Swerdlow NR. Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults. Psychopharmacology. 227: 165-76. PMID 23314393 DOI: 10.1007/s00213-012-2948-x  0.348
2013 Swerdlow NR. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Neuroscience and Biobehavioral Reviews. 37: 1150-6. PMID 23017868 DOI: 10.1016/j.neubiorev.2012.09.002  0.34
2013 Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neuroscience and Biobehavioral Reviews. 37: 1139-49. PMID 23010529 DOI: 10.1016/J.Neubiorev.2012.09.007  0.313
2012 Chou HH, Twamley E, Swerdlow NR. Towards medication-enhancement of cognitive interventions in schizophrenia. Handbook of Experimental Pharmacology. 81-111. PMID 23027413 DOI: 10.1007/978-3-642-25758-2_4  0.356
2012 Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. Plos One. 7: e39434. PMID 22802938 DOI: 10.1371/Journal.Pone.0039434  0.392
2012 Swerdlow NR, Shilling PD, Breier M, Trim RS, Light GA, Marie RS. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology. 224: 349-62. PMID 22700037 DOI: 10.1007/S00213-012-2758-1  0.4
2012 Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y, Sprock J, Pela M, Light GA. Disentangling early sensory information processing deficits in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 123: 1942-9. PMID 22608970 DOI: 10.1016/J.Clinph.2012.02.079  0.408
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  0.448
2012 Kirihara K, Rissling AJ, Swerdlow NR, Braff DL, Light GA. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biological Psychiatry. 71: 873-80. PMID 22361076 DOI: 10.1016/J.Biopsych.2012.01.016  0.384
2012 Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. Plos One. 7: e29630. PMID 22253750 DOI: 10.1371/Journal.Pone.0029630  0.398
2012 Chang WL, Weber M, Breier MR, Saint Marie RL, Hines SR, Swerdlow NR. Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats. Brain Research. 1437: 69-76. PMID 22227455 DOI: 10.1016/J.Brainres.2011.12.007  0.565
2012 Swerdlow NR. Beyond antipsychotics: pharmacologically-augmented cognitive therapies (PACTs) for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 310-1. PMID 22157876 DOI: 10.1038/npp.2011.195  0.365
2011 Chang WL, Breier MR, Yang A, Swerdlow NR. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 99: 634-8. PMID 21683731 DOI: 10.1016/J.Pbb.2011.06.002  0.576
2011 Swerdlow NR. Are we studying and treating schizophrenia correctly? Schizophrenia Research. 130: 1-10. PMID 21645998 DOI: 10.1016/j.schres.2011.05.004  0.365
2011 Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, ... ... Swerdlow NR, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 168: 930-46. PMID 21498463 DOI: 10.1176/Appi.Ajp.2011.10050723  0.352
2011 Swerdlow NR, Breier MR, Saint Marie RL. Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats. Psychopharmacology. 216: 401-10. PMID 21365203 DOI: 10.1007/s00213-011-2228-1  0.424
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, ... ... Swerdlow NR, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/J.Schres.2011.01.005  0.381
2010 Swerdlow NR. Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias. Current Topics in Behavioral Neurosciences. 4: 555-83. PMID 21312413 DOI: 10.1007/7854_2010_48  0.359
2010 Chang WL, Swerdlow NR, Breier MR, Thangaraj N, Weber M. Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats. Pharmacology, Biochemistry, and Behavior. 95: 473-8. PMID 20385162 DOI: 10.1016/J.Pbb.2010.04.001  0.575
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, ... ... Swerdlow NR, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/J.Schres.2010.03.004  0.4
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, ... ... Swerdlow NR, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/J.1469-8986.2010.01004.X  0.393
2010 Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 421-5. PMID 20346635 DOI: 10.1016/J.Euroneuro.2010.02.011  0.564
2010 Saint Marie RL, Miller EJ, Breier MR, Weber M, Swerdlow NR. Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience. 168: 498-504. PMID 20338222 DOI: 10.1016/j.neuroscience.2010.03.037  0.359
2010 Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behavioural Pharmacology. 21: 135-43. PMID 20215963 DOI: 10.1097/Fbp.0B013E328337Be7E  0.498
2010 Breier MR, Lewis B, Shoemaker JM, Light GA, Swerdlow NR. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. Behavioural Brain Research. 208: 560-5. PMID 20080128 DOI: 10.1016/J.Bbr.2009.12.037  0.418
2010 Miller EJ, Saint Marie LR, Breier MR, Swerdlow NR. Pathways from the ventral hippocampus and caudal amygdala to forebrain regions that regulate sensorimotor gating in the rat. Neuroscience. 165: 601-11. PMID 19854244 DOI: 10.1016/j.neuroscience.2009.10.036  0.36
2010 Light GA, Greenwood T, Sprock J, Swerdlow N, Braff D. Use of neurophysiological biomarkers for understanding the pathways from genes to real-world daily functioning in schizophrenia Neuroscience Research. 68: e49. DOI: 10.1016/J.Neures.2010.07.463  0.336
2010 Swerdlow NR, Braff DL, Bakshi VP, Geyer MA. An Animal Model of Sensorimotor Gating Deficits in Schizophrenia Predicts Antipsychotic Drug Action Handbook of Experimental Pharmacology. 120: 289-312. DOI: 10.1007/978-3-642-61007-3_10  0.337
2009 Qu Y, Saint Marie RL, Breier MR, Ko D, Stouffer D, Parsons LH, Swerdlow NR. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats. Psychopharmacology. 207: 271-80. PMID 19756524 DOI: 10.1007/S00213-009-1654-9  0.647
2009 Swerdlow NR, Lelham SA, Sutherland Owens AN, Chang WL, Sassen SD, Talledo JA. Pramipexole effects on startle gating in rats and normal men. Psychopharmacology. 205: 689-98. PMID 19506839 DOI: 10.1007/S00213-009-1577-5  0.553
2009 Weber M, Chang WL, Durbin JP, Park PE, Luedtke RR, Mach RH, Swerdlow NR. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacology, Biochemistry, and Behavior. 93: 141-7. PMID 19426754 DOI: 10.1016/J.Pbb.2009.04.022  0.534
2009 Swerdlow NR, van Bergeijk DP, Bergsma F, Weber E, Talledo J. The effects of memantine on prepulse inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1854-64. PMID 19242406 DOI: 10.1038/npp.2009.7  0.385
2009 Talledo JA, Sutherland Owens AN, Schortinghuis T, Swerdlow NR. Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology. 204: 165-75. PMID 19148623 DOI: 10.1007/s00213-008-1446-7  0.406
2009 Weber M, Breier M, Ko D, Thangaraj N, Marzan DE, Swerdlow NR. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine. Psychopharmacology. 203: 723-35. PMID 19066855 DOI: 10.1007/s00213-008-1419-x  0.467
2009 Light G, Greenwood T, Rissling A, Pela M, Sprock J, Swerdlow N, Braff D. MMN is associated with genetic, clinical, cognitive, & functional abnormalities of schizophrenia Neuroscience Research. 65: S8. DOI: 10.1016/J.Neures.2009.09.1516  0.352
2008 Weber M, Chang WL, Breier M, Ko D, Swerdlow NR. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behavioural Pharmacology. 19: 786-95. PMID 19020413 DOI: 10.1097/Fbp.0B013E32831C3B2B  0.536
2008 Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, ... ... Swerdlow NR, et al. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biological Psychiatry. 64: 1051-9. PMID 18701089 DOI: 10.1016/J.Biopsych.2008.06.018  0.392
2008 Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacology, Biochemistry, and Behavior. 90: 686-90. PMID 18579193 DOI: 10.1016/J.Pbb.2008.05.012  0.669
2008 Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 199: 331-88. PMID 18568339 DOI: 10.1007/S00213-008-1072-4  0.416
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ. Advances in endophenotyping schizophrenia. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 11-8. PMID 18458787 DOI: 10.1002/J.2051-5545.2008.Tb00140.X  0.377
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, ... ... Swerdlow NR, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.383
2008 Shilling PD, Saint Marie RL, Shoemaker JM, Swerdlow NR. Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways. Biological Psychiatry. 63: 748-58. PMID 18083141 DOI: 10.1016/j.biopsych.2007.10.015  0.428
2008 Swerdlow NR, Breier M, Mora AB, Ko D, Shoemaker JM. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacology, Biochemistry, and Behavior. 88: 280-90. PMID 17936348 DOI: 10.1016/j.pbb.2007.08.013  0.395
2008 Weber M, Swerdlow NR. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses. Pharmacology, Biochemistry, and Behavior. 88: 306-11. PMID 17900675 DOI: 10.1016/j.pbb.2007.08.014  0.445
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, ... ... Swerdlow NR, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/Archpsyc.64.11.1242  0.373
2007 Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 893-8. PMID 17594127 DOI: 10.1007/S00702-007-0627-6  0.409
2007 Swerdlow NR, Shoemaker JM, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Pharmacology, Biochemistry, and Behavior. 87: 1-10. PMID 17475315 DOI: 10.1016/j.pbb.2007.03.014  0.423
2007 Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/J.Schres.2007.01.012  0.35
2007 Braff DL, Light GA, Swerdlow NR. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biological Psychiatry. 61: 1204-7. PMID 17161386 DOI: 10.1016/J.Biopsych.2006.08.015  0.358
2007 Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin. 33: 69-94. PMID 17135482 DOI: 10.1093/Schbul/Sbl060  0.412
2007 Swerdlow NR, Blumenthal TD, Sutherland AN, Weber E, Talledo JA. Effects of prepulse intensity, duration, and bandwidth on perceived intensity of startling acoustic stimuli. Biological Psychology. 74: 389-95. PMID 17118517 DOI: 10.1016/J.Biopsycho.2006.10.001  0.327
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, ... ... Swerdlow NR, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.349
2007 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, ... ... Swerdlow NR, et al. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research. 89: 320-9. PMID 17023145 DOI: 10.1016/J.Schres.2006.08.010  0.371
2006 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry. 63: 1325-35. PMID 17146007 DOI: 10.1001/Archpsyc.63.12.1325  0.385
2006 Saint Marie RL, Neary AC, Shoemaker JM, Swerdlow NR. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny. Brain Research. 1119: 203-14. PMID 16979142 DOI: 10.1016/j.brainres.2006.08.045  0.371
2006 Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, Braff DL. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biological Psychiatry. 60: 1231-40. PMID 16893524 DOI: 10.1016/J.Biopsych.2006.03.055  0.372
2006 Swerdlow NR, Shoemaker JM, Kuczenski R, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neuroscience Letters. 402: 40-5. PMID 16644125 DOI: 10.1016/J.Neulet.2006.03.060  0.459
2006 Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology. 186: 246-54. PMID 16583235 DOI: 10.1007/s00213-006-0374-7  0.439
2006 Swerdlow NR, Sprock J, Braff DL. Prepulse-elicited motor reactions do not differ between schizophrenia patients and control subjects. Behavioral Neuroscience. 120: 224-7. PMID 16492135 DOI: 10.1037/0735-7044.120.1.224  0.391
2006 Swerdlow NR, Talledo J, Sutherland AN, Nagy D, Shoemaker JM. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2011-21. PMID 16482083 DOI: 10.1038/sj.npp.1301043  0.445
2006 Hsieh MH, Swerdlow NR, Braff DL. Effects of background and prepulse characteristics on prepulse inhibition and facilitation: implications for neuropsychiatric research. Biological Psychiatry. 59: 555-9. PMID 16169529 DOI: 10.1016/j.biopsych.2005.07.032  0.375
2006 Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 506-15. PMID 16123772 DOI: 10.1038/Sj.Npp.1300841  0.39
2006 Swerdlow NR, Krupin AS, Bongiovanni MJ, Shoemaker JM, Goins JC, Hammer RP. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 721-9. PMID 16123742 DOI: 10.1038/sj.npp.1300877  0.421
2005 Swerdlow NR, Shoemaker JM, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Pharmacology, Biochemistry, and Behavior. 82: 293-9. PMID 16188305 DOI: 10.1016/j.pbb.2005.08.018  0.419
2005 Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, Swerdlow NR. Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats. Neuroscience. 135: 385-94. PMID 16125865 DOI: 10.1016/j.neuroscience.2005.06.054  0.382
2005 Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR. Female schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry. 57: 817-20. PMID 15820241 DOI: 10.1016/J.Biopsych.2004.12.030  0.359
2005 Swerdlow NR, Stephany NL, Talledo J, Light G, Braff DL, Baeyens D, Auerbach PP. Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Biological Psychology. 69: 133-47. PMID 15804542 DOI: 10.1016/J.Biopsycho.2004.07.002  0.315
2005 Swerdlow NR, Talledo JA, Braff DL. Startle modulation in Caucasian-Americans and Asian-Americans: a prelude to genetic/endophenotypic studies across the 'Pacific Rim'. Psychiatric Genetics. 15: 61-5. PMID 15722959 DOI: 10.1097/00041444-200503000-00010  0.33
2005 Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM. Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacology, Biochemistry, and Behavior. 80: 203-11. PMID 15680173 DOI: 10.1016/J.Pbb.2004.11.002  0.422
2005 Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Minassian A, Auerbach PP. Intact visual latent inhibition in schizophrenia patients in a within-subject paradigm. Schizophrenia Research. 72: 169-83. PMID 15560962 DOI: 10.1016/j.schres.2004.03.022  0.411
2004 Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Biological Psychiatry. 56: 296-9. PMID 15312819 DOI: 10.1016/J.Biopsych.2004.06.009  0.389
2004 Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology. 174: 452-62. PMID 15300359 DOI: 10.1007/s00213-003-1480-4  0.407
2004 Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Auerbach PP. Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacology. 174: 441-51. PMID 15300358 DOI: 10.1007/s00213-003-1481-3  0.431
2004 Swerdlow NR, Talledo J, Shoemaker JM, Codon K, Goins J, Auerbach PP. Weak prepulses inhibit but do not elicit startle in rats and humans. Biological Psychiatry. 55: 1195-8. PMID 15184039 DOI: 10.1016/j.biopsych.2004.02.030  0.378
2004 Swerdlow NR, Shoemaker JM, Crain S, Goins J, Onozuka K, Auerbach PP. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Pharmacology, Biochemistry, and Behavior. 77: 291-302. PMID 14751457 DOI: 10.1016/j.pbb.2003.11.008  0.386
2004 Swerdlow NR, Shoemaker JM, Noh HR, Ma L, Gaudet I, Munson M, Crain S, Auerbach PP. The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix. Neuroscience. 123: 675-85. PMID 14706779 DOI: 10.1016/j.neuroscience.2003.08.028  0.418
2003 Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience. 119: 233-40. PMID 12763084 DOI: 10.1016/S0306-4522(03)00122-2  0.435
2003 Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacology, Biochemistry, and Behavior. 75: 191-7. PMID 12759127 DOI: 10.1016/S0091-3057(03)00078-9  0.419
2003 Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker J, Auerbach PP. Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 640-50. PMID 12655308 DOI: 10.1038/sj.npp.1300086  0.401
2003 Shoemaker JM, Pitcher L, Noh HR, Swerdlow NR. Quetiapine produces a prolonged reversal of the sensorimotor gating-disruptive effects of basolateral amygdala lesions in rats. Behavioral Neuroscience. 117: 136-43. PMID 12619916 DOI: 10.1037/0735-7044.117.1.136  0.419
2003 Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology. 169: 314-20. PMID 12610717 DOI: 10.1007/s00213-002-1325-6  0.416
2003 Swerdlow NR, Platten A, Hanlon FM, Martinez ZA, Printz MP, Auerbach P. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 226-34. PMID 12589375 DOI: 10.1038/Sj.Npp.1300035  0.391
2003 Swerdlow NR, Wasserman LC, Talledo JA, Casas R, Bruins P, Stephany NL. Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biological Psychology. 62: 17-26. PMID 12505765 DOI: 10.1016/S0301-0511(02)00090-X  0.352
2002 Swerdlow NR, Pitcher L, Noh HR, Shoemaker JM. Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Brain Research. 953: 246-54. PMID 12384258 DOI: 10.1016/S0006-8993(02)03298-5  0.489
2002 Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J, Auerbach PP. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology. 164: 82-92. PMID 12373422 DOI: 10.1007/s00213-002-1172-5  0.392
2002 Powell SB, Swerdlow NR, Pitcher LK, Geyer MA. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiology & Behavior. 77: 55-64. PMID 12213502 DOI: 10.1016/S0031-9384(02)00817-X  0.388
2002 Swerdlow NR, Shoemaker JM, Pitcher L, Platten A, Kuczenski R, Eleey CC, Auerbach P. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behavioral Neuroscience. 116: 682-90. PMID 12148935 DOI: 10.1037//0735-7044.116.4.682  0.441
2002 Swerdlow NR, Shoemaker JM, Stephany N, Wasserman L, Ro HJ, Geyer MA. Prestimulus effects on startle magnitude: sensory or motor? Behavioral Neuroscience. 116: 672-81. PMID 12148934 DOI: 10.1037//0735-7044.116.4.672  0.336
2002 Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology. 161: 189-201. PMID 11981599 DOI: 10.1007/S00213-002-1040-3  0.413
2002 Martinez ZA, Platten A, Pollack E, Shoemaker J, Ro H, Pitcher L, Geyer MA, Swerdlow NR. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats. Psychopharmacology. 161: 38-46. PMID 11967629 DOI: 10.1007/S00213-001-0977-Y  0.465
2001 Geyer MA, Swerdlow NR. Measurement of startle response, prepulse inhibition, and habituation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.7. PMID 18428548 DOI: 10.1002/0471142301.ns0807s03  0.357
2001 Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P. Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 158: 230-40. PMID 11713612 DOI: 10.1007/s002130100856  0.322
2001 Swerdlow NR, Platten A, Kim YK, Gaudet I, Shoemaker J, Pitcher L, Auerbach P. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Pharmacology, Biochemistry, and Behavior. 70: 219-26. PMID 11701191 DOI: 10.1016/S0091-3057(01)00598-6  0.423
2001 Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biological Psychiatry. 50: 578-85. PMID 11690592 DOI: 10.1016/S0006-3223(01)01164-7  0.336
2001 Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156: 234-58. PMID 11549226 DOI: 10.1007/s002130100810  0.407
2001 Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156: 117-54. PMID 11549216 DOI: 10.1007/s002130100811  0.458
2001 Swerdlow NR, Halim N, Hanlon FM, Platten A, Auerbach PP. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less. Brain Research Bulletin. 55: 71-7. PMID 11427340 DOI: 10.1016/S0361-9230(01)00492-0  0.333
2001 Swerdlow NR. Obsessive-compulsive disorder and tic syndromes. The Medical Clinics of North America. 85: 735-55. PMID 11349482 DOI: 10.1016/S0025-7125(05)70338-2  0.305
2001 Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research. 49: 171-8. PMID 11343875 DOI: 10.1016/S0920-9964(00)00139-0  0.42
2001 Swerdlow NR, Hanlon FM, Henning L, Kim YK, Gaudet I, Halim ND. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Brain Research. 898: 195-203. PMID 11306005 DOI: 10.1016/S0006-8993(01)02143-6  0.376
2000 Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behavioural Pharmacology. 11: 185-204. PMID 11103873 DOI: 10.1097/00008877-200006000-00002  0.382
2000 Farid M, Martinez ZA, Geyer MA, Swerdlow NR. Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 623-32. PMID 11063918 DOI: 10.1016/S0893-133X(00)00163-9  0.421
2000 Martinez ZA, Oostwegel J, Geyer MA, Ellison GD, Swerdlow NR. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 517-27. PMID 11027917 DOI: 10.1016/S0893-133X(00)00147-0  0.463
2000 Swerdlow NR, Eastvold A, Gerbranda T, Uyan KM, Hartman P, Doan Q, Auerbach P. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology. 151: 368-78. PMID 11026744 DOI: 10.1007/s002130000490  0.349
2000 Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. The American Journal of Psychiatry. 157: 1660-8. PMID 11007721 DOI: 10.1176/appi.ajp.157.10.1660  0.389
2000 Halim ND, Swerdlow NR. Distributed neurodegenerative changes 2-28 days after ventral hippocampal excitotoxic lesions in rats. Brain Research. 873: 60-74. PMID 10915811 DOI: 10.1016/S0006-8993(00)02497-5  0.372
2000 Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4325-36. PMID 10818168 DOI: 10.1523/Jneurosci.20-11-04325.2000  0.434
2000 Swerdlow NR, Taaid N, Halim N, Randolph E, Kim YK, Auerbach P. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience. 96: 523-36. PMID 10717433 DOI: 10.1016/S0306-4522(99)00528-X  0.405
2000 Martinez ZA, Halim ND, Oostwegel JL, Geyer MA, Swerdlow NR. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacology, Biochemistry, and Behavior. 65: 449-57. PMID 10683485 DOI: 10.1016/S0091-3057(99)00217-8  0.481
2000 Cadenhead K, Swerdlow N, Shafer K, Braff D. 404. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and schizotypal subjects: evidence of inhibitory deficits Biological Psychiatry. 47: S123-S124. DOI: 10.1016/S0006-3223(00)00674-0  0.35
2000 Swerdlow N, Martinez Z, Hanlon F, Auerbach P, Platten A, Braff D, Geyer M. 121. Towards the genetics of a complex phenotype: strain analyses of drug effects on startle gating Biological Psychiatry. 47: S37. DOI: 10.1016/S0006-3223(00)00383-8  0.399
2000 Martinez Z, Oostwegel J, Geyer M, Ellison G, Swerdlow N. 119. Sustained haloperidol opposes apomorphine and phencyclidine-induced startle gating deficits Biological Psychiatry. 47: S36. DOI: 10.1016/S0006-3223(00)00381-4  0.396
1999 Swerdlow NR, Braff DL, Geyer MA. Cross-species studies of sensorimotor gating of the startle reflex. Annals of the New York Academy of Sciences. 877: 202-16. PMID 10415651 DOI: 10.1111/j.1749-6632.1999.tb09269.x  0.385
1999 Geyer MA, Swerdlow NR, Lehmann-Masten V, Teschendorf HJ, Traut M, Gross G. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats. The Journal of Pharmacology and Experimental Therapeutics. 290: 716-24. PMID 10411583  0.359
1999 Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 28-39. PMID 10379517 DOI: 10.1016/S0893-133X(98)00137-7  0.4
1999 Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacology. 142: 253-60. PMID 10208317 DOI: 10.1007/S002130050887  0.386
1999 Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. The American Journal of Psychiatry. 156: 596-602. PMID 10200740 DOI: 10.1176/AJP.156.4.596  0.402
1999 Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biological Psychiatry. 45: 360-4. PMID 10023514 DOI: 10.1016/S0006-3223(98)00294-7  0.39
1999 Swerdlow NR, Geyer MA, Blumenthal TD, Hartman PL. Effects of discrete acoustic prestimuli on perceived intensity and behavioral responses to startling acoustic and tactile stimuli Psychobiology. 27: 547-556. DOI: 10.3758/Bf03332152  0.341
1999 Swerdlow NR, Young AB. Neuropathology in Tourette Syndrome Cns Spectrums. 4: 65-74. DOI: 10.1017/S1092852900000833  0.322
1998 Swerdlow NR, Bakshi V, Waikar M, Taaid N, Geyer MA. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology. 140: 75-80. PMID 9862405 DOI: 10.1007/s002130050741  0.463
1998 Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA. Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural Pharmacology. 9: 389-96. PMID 9832924 DOI: 10.1097/00008877-199809000-00002  0.455
1998 Hart S, Zreik M, Carper R, Swerdlow NR. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. Pharmacology, Biochemistry, and Behavior. 61: 113-9. PMID 9715813 DOI: 10.1016/S0091-3057(98)00079-3  0.467
1998 Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24: 285-301. PMID 9613626 DOI: 10.1093/OXFORDJOURNALS.SCHBUL.A033326  0.482
1998 Bakshi VP, Swerdlow NR, Braff DL, Geyer MA. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biological Psychiatry. 43: 436-45. PMID 9532349 DOI: 10.1016/S0006-3223(97)00246-1  0.452
1998 Swerdlow NR, Varty GB, Geyer MA. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 50-6. PMID 9408918 DOI: 10.1016/S0893-133X(97)00110-3  0.416
1998 Cadenhead K, Geyer M, Swerdlow N, Shafer K, Diaz M, Clementz B, Braff D. 33. Sensorimotor gating deficits in schizophrenic patients and their relatives Biological Psychiatry. 43: S10-S11. DOI: 10.1016/S0006-3223(98)90481-4  0.328
1997 Kodsi MH, Swerdlow NR. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Research. 773: 45-52. PMID 9409703 DOI: 10.1016/S0006-8993(97)00869-X  0.359
1997 Braff DL, Swerdlow NR. Neuroanatomy of schizophrenia. Schizophrenia Bulletin. 23: 509-12. PMID 9327513 DOI: 10.1093/Schbul/23.3.509  0.394
1997 Kodsi MH, Swerdlow NR. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Neuroscience Letters. 231: 103-7. PMID 9291151 DOI: 10.1016/S0304-3940(97)00482-5  0.37
1997 Feifel D, Minor KL, Dulawa S, Swerdlow NR. The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Research. 760: 80-4. PMID 9237521 DOI: 10.1016/0006-3223(96)84232-6  0.45
1997 Feifel D, Swerdlow NR. The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin. Neuroscience Letters. 229: 5-8. PMID 9224788 DOI: 10.1016/S0304-3940(97)00409-6  0.469
1997 Kodsi MH, Swerdlow NR. Regulation of prepulse inhibition by ventral pallidal projections. Brain Research Bulletin. 43: 219-28. PMID 9222535 DOI: 10.1016/S0361-9230(96)00440-6  0.336
1997 Wan FJ, Swerdlow NR. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience. 76: 715-24. PMID 9135045 DOI: 10.1016/S0306-4522(96)00218-7  0.332
1997 Farber RH, Clementz BA, Swerdlow NR. Characteristics of open- and closed-loop smooth pursuit responses among obsessive-compulsive disorder, schizophrenia, and nonpsychiatric individuals. Psychophysiology. 34: 157-62. PMID 9090264 DOI: 10.1111/J.1469-8986.1997.Tb02126.X  0.354
1997 Geyer MA, Bakshi V, Braff DL, Swerdlow NR. Developmentally specific disruptions of prepulse inhibition: Sensitivity to antipsychotics Schizophrenia Research. 24: 76-77. DOI: 10.1016/S0920-9964(97)82207-4  0.34
1997 Braff D, Swerdlow N, Perry W, Cadenhead K, Geyer M. Information processing (prepulsive inhibition) deficits in schizophrenia Biological Psychiatry. 42: 131S. DOI: 10.1016/S0006-3223(97)87437-9  0.38
1996 Swerdlow NR, Bakshi V, Geyer MA. Seroquel restores sensorimotor gating in phencyclidine-treated rats. The Journal of Pharmacology and Experimental Therapeutics. 279: 1290-9. PMID 8968353  0.362
1996 Wan FJ, Caine SB, Swerdlow NR. The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. European Journal of Pharmacology. 314: 9-18. PMID 8957213 DOI: 10.1016/S0014-2999(96)00535-3  0.385
1996 Wan FJ, Taaid N, Swerdlow NR. Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 265-74. PMID 8924194 DOI: 10.1016/0893-133X(95)00133-X  0.341
1996 Wan FJ, Swerdlow NR. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Research. 722: 168-76. PMID 8813362 DOI: 10.1016/0006-8993(96)00209-0  0.482
1996 Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. Latent inhibition in schizophrenia. Schizophrenia Research. 20: 91-103. PMID 8794497 DOI: 10.1016/0920-9964(95)00097-6  0.394
1996 Swerdlow N, Bakshi V, Geyer M. Seroquel restores prepulse inhibition of startle in phencyclidine-treated rats European Neuropsychopharmacology. 6: 107. DOI: 10.1016/0924-977X(96)87794-7  0.359
1995 Bakshi VP, Geyer MA, Taaid N, Swerdlow NR. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behavioural Pharmacology. 6: 801-809. PMID 11224383  0.374
1995 Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122: 35-43. PMID 8711062 DOI: 10.1007/BF02246439  0.418
1995 Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122: 27-34. PMID 8711061 DOI: 10.1007/BF02246438  0.442
1995 Wan FJ, Geyer MA, Swerdlow NR. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology. 120: 433-41. PMID 8539324 DOI: 10.1007/BF02245815  0.446
1995 Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 192-200. PMID 7876851 DOI: 10.1136/Jnnp.58.2.192  0.35
1995 Caine SB, Geyer MA, Swerdlow NR. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 12: 139-45. PMID 7779242 DOI: 10.1016/0893-133X(94)00071-7  0.413
1995 Swerdlow NR, Filion D, Geyer MA, Braff DL. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biological Psychiatry. 37: 286-99. PMID 7748980 DOI: 10.1016/0006-3223(94)00138-S  0.319
1995 Kodsi MH, Swerdlow NR. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle. Brain Research. 684: 26-35. PMID 7583201 DOI: 10.1016/0006-8993(95)00372-W  0.315
1995 Swerdlow NR. Serotonin, obsessive compulsive disorder and the basal ganglia International Review of Psychiatry. 7: 115-129. DOI: 10.3109/09540269509022980  0.308
1995 Swerdlow NR. Don't leave the “un” off “consciousness” Behavioral and Brain Sciences. 18: 699-700. DOI: 10.1017/S0140525X00040656  0.323
1995 Braff D, Perry W, Cadenhead K, Swerdlow N, Geyer M. Prepulse inhibitory deficits in schizophrenia: Gender effects Biological Psychiatry. 37: 654. DOI: 10.1016/0006-3223(95)94629-B  0.32
1994 Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry. 51: 139-54. PMID 8297213 DOI: 10.1001/ARCHPSYC.1994.03950020063007  0.491
1994 Kodsi MH, Swerdlow NR. Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Research. 643: 59-65. PMID 8032933 DOI: 10.1016/0006-8993(94)90008-6  0.401
1994 Bakshi VP, Swerdlow NR, Geyer MA. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. The Journal of Pharmacology and Experimental Therapeutics. 271: 787-94. PMID 7965797  0.318
1994 Swerdlow NR, Britton KT. Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine. Psychopharmacology. 115: 141-6. PMID 7862886 DOI: 10.1007/Bf02244764  0.312
1994 Swerdlow NR, Zisook D, Taaid N. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine. Psychopharmacology. 114: 675-8. PMID 7855231 DOI: 10.1007/Bf02245001  0.443
1994 Wan FJ, Geyer MA, Swerdlow NR. Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmacology, Biochemistry, and Behavior. 49: 155-63. PMID 7816867 DOI: 10.1016/0091-3057(94)90470-7  0.405
1994 Swerdlow N, Lipska B, Weinberger D, Braff D, Jaskiw G, Geyer M. Startle gating after frontal cortex or hippocampal lesions in adult rats Biological Psychiatry. 35: 707. DOI: 10.1016/0006-3223(94)90987-3  0.475
1994 Lipska B, Swerdlow N, Jaskiw G, Geyer M, Braff D, Weinberger D. Neonatal hippocampal damage disrupts sensorimotor gating in postpubertal rats Biological Psychiatry. 35: 631-632. DOI: 10.1016/0006-3223(94)90719-6  0.319
1994 Bakshi V, Geyer M, Taaid N, Swerdlow N. Similar effects of stimulants on latent inhibition and prepulse inhibition Biological Psychiatry. 35: 631. DOI: 10.1016/0006-3223(94)90716-1  0.318
1994 Braff D, Filion D, Swerdlow N, Cadenhead K, Geyer M. Voluntary and involuntary attentional deficits in schizophrenia Biological Psychiatry. 35: 615. DOI: 10.1016/0006-3223(94)90659-9  0.37
1993 Swerdlow NR, Geyer MA. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacology, Biochemistry, and Behavior. 44: 741-4. PMID 8451276 DOI: 10.1016/0091-3057(93)90193-W  0.488
1993 Swerdlow NR, Geyer MA. Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus. Behavioral Neuroscience. 107: 104-17. PMID 8447948 DOI: 10.1037/0735-7044.107.1.104  0.403
1993 Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, Braff DL. Men are more inhibited than women by weak prepulses. Biological Psychiatry. 34: 253-60. PMID 8399822 DOI: 10.1016/0006-3223(93)90079-S  0.306
1993 Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacology, Biochemistry, and Behavior. 45: 629-37. PMID 8392732 DOI: 10.1016/0091-3057(93)90518-X  0.478
1993 Wan FJ, Swerdlow NR. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology. 113: 103-9. PMID 7862814 DOI: 10.1007/BF02244341  0.479
1993 Swerdlow N, Wan F, Geyer M. Nucleus accumbens D2 dopamine receptor activation impairs startle gating in rats Schizophrenia Research. 9: 253. DOI: 10.1016/0920-9964(93)90578-7  0.405
1992 Swerdlow NR, Caine SB, Braff DL, Geyer MA. The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. Journal of Psychopharmacology (Oxford, England). 6: 176-90. PMID 22291349 DOI: 10.1177/026988119200600210  0.404
1992 Caine SB, Geyer MA, Swerdlow NR. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacology, Biochemistry, and Behavior. 43: 1201-8. PMID 1475305 DOI: 10.1016/0091-3057(92)90503-8  0.406
1992 Swerdlow NR, Caine SB, Geyer MA. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 108: 189-95. PMID 1410139 DOI: 10.1007/BF02245306  0.414
1991 Swerdlow NR, Caine SB, Geyer MA. Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 15: 415-26. PMID 1862221 DOI: 10.1016/0278-5846(91)90072-9  0.424
1991 Swerdlow NR, Keith VA, Braff DL, Geyer MA. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. The Journal of Pharmacology and Experimental Therapeutics. 256: 530-6. PMID 1825226  0.373
1991 Caine SB, Geyer MA, Swerdlow NR. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psychopharmacology. 105: 347-54. PMID 1798831 DOI: 10.1007/BF02244429  0.474
1991 Koob GF, Swerdlow NR, Vaccarino F, Hubner C, Pulvirenti L, Weiss F. Functional output of the basal forebrain. Advances in Experimental Medicine and Biology. 295: 291-305. PMID 1776573 DOI: 10.1007/978-1-4757-0145-6_15  0.564
1991 Pulvirenti L, Swerdlow NR, Koob GF. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacology, Biochemistry, and Behavior. 40: 841-5. PMID 1687766 DOI: 10.1016/0091-3057(91)90095-J  0.501
1991 Swerdlow NR. Neuropsychology of schizophrenia: The “hole” thing is wrong Behavioral and Brain Sciences. 14: 51-53. DOI: 10.1017/S0140525X00065389  0.374
1990 Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology. 102: 1-4. PMID 2392496 DOI: 10.1007/Bf02245735  0.343
1990 Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100: 413-6. PMID 2315438 DOI: 10.1007/BF02244616  0.555
1990 Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Research Bulletin. 25: 485-98. PMID 2292046 DOI: 10.1016/0361-9230(90)90241-Q  0.421
1990 Swerdlow NR, Braff DL, Geyer MA. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Research. 532: 146-50. PMID 2282510 DOI: 10.1016/0006-8993(90)91754-5  0.434
1990 Swerdlow NR, Braff DL, Masten VL, Geyer MA. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101: 414-20. PMID 2114026 DOI: 10.1007/BF02244063  0.46
1990 Swerdlow NR, Koob GF. Toward a unified hypothesis of cortico-striato-pallido-thalamus function? Behavioral and Brain Sciences. 13: 172-177. DOI: 10.1017/S0140525X00078195  0.407
1989 Pulvirenti L, Swerdlow NR, Koob GF. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neuroscience Letters. 103: 213-8. PMID 2771183 DOI: 10.1016/0304-3940(89)90578-8  0.522
1989 Swerdlow NR, Britton KT, Koob GF. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2: 285-92. PMID 2610824 DOI: 10.1016/0893-133X(89)90033-X  0.361
1989 Swerdlow NR, Koob GF. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine. Pharmacology, Biochemistry, and Behavior. 33: 595-9. PMID 2511575 DOI: 10.1016/0091-3057(89)90394-8  0.548
1988 Gold LH, Swerdlow NR, Koob GF. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behavioral Neuroscience. 102: 544-52. PMID 3139012 DOI: 10.1037//0735-7044.102.4.544  0.643
1988 Koob GF, Swerdlow NR. The functional output of the mesolimbic dopamine system. Annals of the New York Academy of Sciences. 537: 216-27. PMID 3059925 DOI: 10.1111/j.1749-6632.1988.tb42108.x  0.477
1987 Swerdlow NR, Koob GF. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Research. 412: 233-43. PMID 3607466 DOI: 10.1016/0006-8993(87)91129-2  0.506
1987 Tazi A, Swerdlow NR, LeMoal M, Rivier J, Vale W, Koob GF. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. Life Sciences. 41: 41-9. PMID 3496511 DOI: 10.1016/0024-3205(87)90554-6  0.461
1987 Swerdlow NR, Amalric M, Koob GF. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus. Pharmacology, Biochemistry, and Behavior. 26: 765-9. PMID 3110795 DOI: 10.1016/0091-3057(87)90609-5  0.527
1987 Swerdlow NR, Koob GF. Toward a unified neuropsychiatric hypothesis Behavioral and Brain Sciences. 10: 226-245. DOI: 10.1017/S0140525X00047683  0.435
1987 Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function Behavioral and Brain Sciences. 10: 197-208. DOI: 10.1017/S0140525X00047488  0.523
1986 Swerdlow NR, Koob GF, Aldenhoff JB. The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat. Psychoneuroendocrinology. 11: 237-40. PMID 3489244 DOI: 10.1016/0306-4530(86)90059-4  0.467
1986 Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. The role of the nucleus raphe pontis and the caudate nucleus in alfentanil rigidity in the rat. Brain Research. 386: 280-6. PMID 3096494 DOI: 10.1016/0006-8993(86)90164-2  0.475
1986 Swerdlow NR, Geyer MA, Vale WW, Koob GF. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology. 88: 147-52. PMID 3081925 DOI: 10.1007/BF00652231  0.5
1986 Vaccarino FJ, Amalric M, Swerdlow NR, Koob GF. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacology, Biochemistry, and Behavior. 24: 61-5. PMID 3080760 DOI: 10.1016/0091-3057(86)90045-6  0.512
1986 Swerdlow NR, Braff DL, Geyer MA, Koob GF. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biological Psychiatry. 21: 23-33. PMID 3080033 DOI: 10.1016/0006-3223(86)90005-3  0.568
1986 Amalric M, Blasco TA, Smith NT, Lee DE, Swerdlow NR, Koob GF. 'Catatonia' produced by alfentanil is reversed by methylnaloxonium microinjections into the brain. Brain Research. 386: 287-95. PMID 3022882 DOI: 10.1016/0006-8993(86)90165-4  0.499
1986 Downs NS, Britton KT, Gibbs DM, Koob GF, Swerdlow NR. Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression? Biological Psychiatry. 21: 775-86. PMID 3015269 DOI: 10.1016/0006-3223(86)90243-X  0.497
1986 Amalric M, Koob GF, Creese I, Swerdlow NR. "Selective" D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. Life Sciences. 39: 1985-93. PMID 2946915 DOI: 10.1016/0024-3205(86)90322-X  0.514
1986 Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacology, Biochemistry, and Behavior. 25: 233-48. PMID 2875470 DOI: 10.1016/0091-3057(86)90261-3  0.452
1986 Bakhit C, Swerdlow N. Behavioral changes following central injection of cysteamine in rats. Brain Research. 365: 159-63. PMID 2868783 DOI: 10.1016/0006-8993(86)90733-X  0.362
1985 Swerdlow NR, Vaccarino FJ, Koob GF. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacology, Biochemistry, and Behavior. 23: 499-501. PMID 4048244 DOI: 10.1016/0091-3057(85)90028-0  0.495
1985 Swerdlow NR, Koob GF. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat. Pharmacology, Biochemistry, and Behavior. 23: 303-7. PMID 3877311 DOI: 10.1016/0091-3057(85)90574-X  0.494
1985 Blasco TA, Lee D, Amalric M, Swerdlow NR, Smith NT, Koob GF. ALFENTANIL-INDUCED RIGIDITY IN THE RAT Anesthesiology. 63: A381. DOI: 10.1097/00000542-198509001-00381  0.476
1984 Swerdlow NR, Swanson LW, Koob GF. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat. Neuroscience Letters. 50: 19-24. PMID 6493625 DOI: 10.1016/0304-3940(84)90455-5  0.494
1984 Swerdlow NR, Koob GF. Restrained rats learn amphetamine-conditioned locomotion, but not place preference. Psychopharmacology. 84: 163-6. PMID 6438675 DOI: 10.1007/BF00427440  0.477
1984 Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation Neuroendocrinology. 39: 450-464. PMID 6096752 DOI: 10.1159/000124021  0.484
1984 Swerdlow NR, Koob GF. The neural substrates of apomorphine-stimulated locomotor activity following denervation of the nucleus accumbens. Life Sciences. 35: 2537-44. PMID 6096659 DOI: 10.1016/0024-3205(84)90440-5  0.494
1984 Swerdlow NR, Swanson LW, Koob GF. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens. Brain Research. 306: 141-8. PMID 6087974 DOI: 10.1016/0006-8993(84)90362-7  0.517
1983 Swerdlow NR, van der Kooy D, Koob GF, Wenger JR. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sciences. 32: 2087-93. PMID 6843283 DOI: 10.1016/0024-3205(83)90096-6  0.465
1983 van der Kooy D, Swerdlow NR, Koob GF. Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions. Brain Research. 259: 111-8. PMID 6824923 DOI: 10.1016/0006-8993(83)91071-5  0.508
1982 Sorenson CA, Swerdlow NR. The effect of tail pinch on the acoustic startle response in rats. Brain Research. 247: 105-13. PMID 7127106 DOI: 10.1016/0006-8993(82)91032-0  0.351
Low-probability matches (unlikely to be authored by this person)
2007 Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, Winey KI, Swerdlow NR, Siegel SJ. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology. 190: 201-11. PMID 17119931 DOI: 10.1007/S00213-006-0616-8  0.3
2000 Hanlon FM, Kim YK, Halim ND, Swerdlow NR. 120. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00382-6  0.299
1995 Braff DL, Swerdlow NR, Geyer MA. Gating and habituation deficits in the schizophrenia disorders. Clinical Neuroscience (New York, N.Y.). 3: 131-9. PMID 7583619  0.297
1997 Perry W, Geyer M, Cadenhead K, Swerdlow N, Braff D. Schizophrenic patients with normal prepulse inhibition? Schizophrenia Research. 24: 231. DOI: 10.1016/S0920-9964(97)82665-5  0.296
1997 Swerdlow NR, Hartman PL, Auerbach PP. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biological Psychiatry. 41: 452-60. PMID 9034539 DOI: 10.1016/S0006-3223(96)00065-0  0.293
2009 Swerdlow NR, Talledo JA. Effects of the first prepulse on the blink response to a startling noise. Behavioral Neuroscience. 123: 607-13. PMID 19485567 DOI: 10.1037/a0015064  0.292
2016 Swerdlow NR, Braff DL, Geyer MA. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. Journal of Psychopharmacology (Oxford, England). PMID 27539931 DOI: 10.1177/0269881116661075  0.292
2017 Perez VB, Tarasenko M, Miyakoshi M, Pianka ST, Makeig SD, Braff DL, Swerdlow NR, Light GA. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28139679 DOI: 10.1038/Npp.2017.25  0.292
1999 Swerdlow NR, Hartston HJ, Hartman PL. Enhanced visual latent inhibition in obsessive-compulsive disorder. Biological Psychiatry. 45: 482-8. PMID 10071722 DOI: 10.1016/S0006-3223(98)00050-X  0.292
2010 Light GA, Williams LE, Minow F, Sprock J, Rissling A, Sharp R, Swerdlow NR, Braff DL. Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 6.25.1-24. PMID 20578033 DOI: 10.1002/0471142301.Ns0625S52  0.291
2016 Swerdlow NR, Bhakta SG, Rana BK, Kei J, Chou HH, Talledo JA. Sensorimotor gating in healthy adults tested over a 15 year period. Biological Psychology. PMID 28027936 DOI: 10.1016/j.biopsycho.2016.12.011  0.289
2017 Huang L, Shum EY, Jones SH, Lou CH, Dumdie J, Kim H, Roberts AJ, Jolly LA, Espinoza JL, Skarbrevik DM, Phan MH, Cook-Andersen H, Swerdlow NR, Gecz J, Wilkinson MF. A Upf3b-mutant mouse model with behavioral and neurogenesis defects. Molecular Psychiatry. PMID 28948974 DOI: 10.1038/Mp.2017.173  0.287
2007 Light GA, Swerdlow NR, Braff DL. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. Journal of Cognitive Neuroscience. 19: 1624-32. PMID 18271737 DOI: 10.1162/Jocn.2007.19.10.1624  0.287
1994 Swerdlow N, Wan F, Caine S, Zisook D, Taaid N, Geyer M. D2 substrates of a measure that predicts atypical antipsychotic potency Biological Psychiatry. 35: 662. DOI: 10.1016/0006-3223(94)90829-X  0.285
2011 Sutherland Owens AN, Miguel EC, Swerdlow NR. Sensory gating scales and premonitory urges in Tourette syndrome. Thescientificworldjournal. 11: 736-41. PMID 21442151 DOI: 10.1100/tsw.2011.57  0.284
2016 Tarasenko M, Perez VB, Pianka ST, Vinogradov S, Braff DL, Swerdlow NR, Light GA. Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia. Schizophrenia Research. PMID 26851143 DOI: 10.1016/J.Schres.2016.01.019  0.283
2016 Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology. PMID 27534540 DOI: 10.1007/S00213-016-4389-4  0.28
2005 Erhardt S, Powell S, Nilsson L, Linderholm K, Swerdlow N, Geyer M. P.2.05. Rats reared in social isolation displaydisrupted ppi and elevated levels of kynurenic acid in the hippocampus European Neuropsychopharmacology. 15: S34-S35. DOI: 10.1016/S0924-977X(05)80145-2  0.278
1996 SWERDLOW NR, BRAFF DL, GEYER MA. BEHAVIORAL MANIFESTATIONS OF THE NICOTINE ABSTINENCE SYNDROME IN RATS Behavioural Pharmacology. 7: 110. DOI: 10.1097/00008877-199605001-00251  0.278
1994 Swerdlow N, Hartman P, Auerbach P. Sensorimotor gating of the human startle reflex: Gender and laterality Biological Psychiatry. 35: 616. DOI: 10.1016/0006-3223(94)90662-9  0.277
2000 Swerdlow NR, Gerbranda T, Hartman P, Eastvold A, Uyan KM, Doan Q, Auerbach P. 122. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects Biological Psychiatry. 47: 37-37. DOI: 10.1016/S0006-3223(00)00384-X  0.277
1995 Kodsi MH, Swerdlow NR. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behavioral Neuroscience. 109: 912-28. PMID 8554715  0.276
2016 Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR. Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology. PMID 27076209 DOI: 10.1007/S00213-016-4291-0  0.275
1999 Swerdlow NR, Zinner S, Farber RH, Seacrist C, Hartston H. Symptoms in obsessive-compulsive disorder and Tourette syndrome: A spectrum? Cns Spectrums. 4: 21-33. DOI: 10.1017/S1092852900000791  0.274
2020 Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, et al. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophrenia Research. PMID 33189519 DOI: 10.1016/j.schres.2020.11.003  0.273
2005 Swerdlow NR, Sutherland AN. Using animal models to develop therapeutics for Tourette Syndrome. Pharmacology & Therapeutics. 108: 281-93. PMID 15970330 DOI: 10.1016/j.pharmthera.2005.05.003  0.272
2019 Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophrenia Research. PMID 30660574 DOI: 10.1016/J.Schres.2018.12.034  0.27
1994 Swerdlow N, Zinner S, Hartston H, Filion D, Magulac M. Central inhibitory deficits in OCD and tourette syndrome Biological Psychiatry. 35: 664. DOI: 10.1016/0006-3223(94)90835-4  0.27
1997 Lipska B, Swerdlow N, Geyer M, Braff D, Weinberger D. Neonatal hippocampal damage disrupts prepulse inhibition of startle Biological Psychiatry. 42: 294S. DOI: 10.1016/S0006-3223(97)88115-2  0.268
2020 Swerdlow NR, Bhakta S, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas M, Joshi Y, Molina JL, Light GA. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32961542 DOI: 10.1038/s41386-020-00865-8  0.257
1998 Roman MJ, Delis DC, Filoteo JV, Demadura TL, Paulsen J, Swerdlow NR, Swenson MR, Salmon D, Butters N, Shults C. Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task. Journal of Clinical and Experimental Neuropsychology. 20: 873-84. PMID 10484698 DOI: 10.1076/Jcen.20.6.873.1111  0.257
1994 Swerdlow N, Paulsen J, Braff D, Butters N, Geyer M, Swenson M. Impaired startle gating in Huntington's disease: Neuropsychological correlates Biological Psychiatry. 35: 632. DOI: 10.1016/0006-3223(94)90720-X  0.257
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Joyce Sprock, Braff DL, Swerdlow NR, Light GA. Neural network dynamics underlying gamma synchronization deficits in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110224. PMID 33340619 DOI: 10.1016/j.pnpbp.2020.110224  0.256
1999 Hartston HJ, Swerdlow NR. Visuospatial priming and stroop performance in patients with obsessive compulsive disorder. Neuropsychology. 13: 447-57. PMID 10447305 DOI: 10.1037/0894-4105.13.3.447  0.256
2006 Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1831-8. PMID 16991144 DOI: 10.1002/Mds.21039  0.255
2000 Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists The Journal of Neuroscience. 20: 4325-4336. DOI: 10.1523/JNEUROSCI.20-11-04325.2000  0.255
1991 Swerdlow NR, Hauger R, Irwin M, Koob GF, Britton KT, Pulvirenti L. Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 5: 23-31. PMID 1657016  0.253
1998 Martinez Z, Geyer M, Ellison G, Swerdlow N. 44. Startle gating deficits during, but not after, sustained exposure to cocaine or phencyclidine Biological Psychiatry. 43: S14. DOI: 10.1016/S0006-3223(98)90492-9  0.252
1999 Farber RH, Swerdlow NR, Clementz BA. Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome. Journal of Neurology, Neurosurgery, and Psychiatry. 66: 305-12. PMID 10084528 DOI: 10.1136/Jnnp.66.3.305  0.252
2010 Swerdlow NR. A cautionary note about latent inhibition in schizophrenia: Are we ignoring relevant information? Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 448-456. DOI: 10.1017/CBO9780511730184.019  0.249
1993 Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biological Psychiatry. 33: 298-301. PMID 8471686 DOI: 10.1016/0006-3223(93)90300-3  0.248
1999 Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology. 146: 228-32. PMID 10525760 DOI: 10.1007/S002130051111  0.248
2021 Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. Schizophrenia Research. 228: 280-287. PMID 33493776 DOI: 10.1016/j.schres.2020.12.042  0.248
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ, Calkins ME, Gur RE, Gur RC, Turetsky BI, Dobie DJ, Radant AD, Tsuang DW, Freedman R, Olincy A, Cadenhead KS, et al. Advances in endophenotyping schizophrenia World Psychiatry. 7: 11-18.  0.245
1985 Swerdlow NR, Lee D, Koob GF, Vaccarino FJ. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat. The Journal of Pharmacology and Experimental Therapeutics. 235: 324-9. PMID 3932641  0.243
2017 Bhakta S, Light G, Talledo J, Balvaneda B, Hughes E, Alvarez A, Rana B, Young J, Swerdlow N. 777. Neural Targets of Tolcapone Enhanced Reverse-Translated 5-Choice Continuous Performance Test (5C-CPT) Performance in COMT-Genotyped Healthy Adults Biological Psychiatry. 81: S315-S316. DOI: 10.1016/J.Biopsych.2017.02.844  0.241
2020 Light GA, Joshi YB, Molina JL, Bhakta SG, Nungaray JA, Cardoso L, Kotz JE, Thomas ML, Swerdlow NR. Neurophysiological biomarkers for schizophrenia therapeutics Biomarkers in Neuropsychiatry. 2: 100012. DOI: 10.1016/j.bionps.2020.100012  0.241
2001 Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156: 194-215. PMID 11549223 DOI: 10.1007/s002130100799  0.24
2013 Bhakta SG, Swerdlow NR. Prefrontal cortex dynfunction and neurocognitive deficits in schizophrenia: Targets of oppurtunity Prefrontal Cortex: Developmental Differences, Executive and Cognitive Functions and Role in Neurological Disorders. 71-128.  0.24
1998 Swerdlow NR. What role models? Commentary on Robbins' homology in behavioural pharmacology: an approach to animal models of human cognition. Behavioural Pharmacology. 9: 529-31. PMID 9862078 DOI: 10.1097/00008877-199811000-00008  0.239
2017 Zhang W, Shiluk A, Rackelmann S, Tarasenko M, Thomas M, Bismark A, Joshi Y, Sprock J, Taylor A, Kauffman C, Cardoso L, Nisco A, Hsiao J, Swerdlow N, Light G. SU62. The 40-Hz Auditory Steady-State Response: A Sensitive and Predictive Biomarker of Perceptual Learning During Cognitive Training Schizophrenia Bulletin. 43: S183-S184. DOI: 10.1093/Schbul/Sbx024.060  0.239
2021 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Vinogradov S, Molina JL, Light GA. Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course. Psychological Medicine. 1-9. PMID 33849683 DOI: 10.1017/S0033291721001239  0.238
2001 Swerdlow NR. PCP-induced PPI deficits in primates Neuroreport. 12: A3.  0.237
1996 Knowlton BJ, Swerdlow NR, Swenson M, Squire LR, Paulsen JS, Butters N. Dissociations within nondeclarative memory in Huntington's disease Neuropsychology. 10: 538-548. DOI: 10.1037/0894-4105.10.4.538  0.236
1995 Paulsen JS, Butters N, Sadek JR, Johnson SA, Salmon DP, Swerdlow NR, Swenson MR. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology. 45: 951-6. PMID 7746413 DOI: 10.1212/Wnl.45.5.951  0.236
1996 Braff D, Geyer M, Perry W, Swerdlow N. Information processing impairment: A clinical & neurodevelopmental perspective Biological Psychiatry. 39: 501. DOI: 10.1016/0006-3223(96)83957-6  0.236
2000 Swerdlow N, Martinez Z, Hanlon F, Farid M, Platten A, Auerbach P. 402. Genetics and neurobiology of sensorimotor gating: the gain in brain comes mainly in the strain Biological Psychiatry. 47: S123. DOI: 10.1016/S0006-3223(00)00672-7  0.235
1992 Downs N, Swerdlow N, Zisook S. The Relationship of Affective Illness and Personality Disorders in Psychiatric Outpatients Annals of Clinical Psychiatry. 4: 87-94. DOI: 10.3109/10401239209150445  0.232
1988 Ruegg RG, Zisook S, Swerdlow NR. Depression in the Aged: Am Overview Psychiatric Clinics of North America. 11: 83-99. DOI: 10.1016/S0193-953X(18)30518-5  0.23
2010 Swerdlow NR. Behavioral neurobiology of schizophrenia and its treatment. Preface. Current Topics in Behavioral Neurosciences. 4: v-vii. PMID 21312394  0.228
2005 Swerdlow NR. Much ado about (almost) nothing: response to 'prepulse lost and regained'. Psychopharmacology. 179: 893-4. PMID 15645219 DOI: 10.1007/s00213-004-2113-2  0.227
1995 Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. Drug screening in "normal" controls. Biological Psychiatry. 38: 123-4. PMID 7578645 DOI: 10.1016/0006-3223(95)00056-M  0.227
1996 Feifel D, Frillman K, Dulawa S, Swerdlow N. Decreased [3H]cAMP binding in postmortem brain in bipolar disorder Biological Psychiatry. 39: 583-584. DOI: 10.1016/0006-3223(96)84233-8  0.226
1996 Swerdlow NR, Perry W. Endocrine regulation of information processing: Animal models and implications for schizophrenia Infertility and Reproductive Medicine Clinics of North America. 7: 279-295.  0.226
2015 Light GA, Swerdlow NR. Bending the curve on psychosis outcomes. The Lancet. Psychiatry. 2: 365-7. PMID 26360262 DOI: 10.1016/S2215-0366(15)00172-8  0.225
1996 Swerdlow NR, Magulac M, Filion D, Zinner S. Visuospatial priming and latent inhibition in children and adults with Tourette's disorder Neuropsychology. 10: 485-494. DOI: 10.1037/0894-4105.10.4.485  0.225
2021 Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophrenia Research. PMID 34187732 DOI: 10.1016/j.schres.2021.06.022  0.223
2006 Mink JW, Hollenbeck PJ, Swerdlow NR, Levi-Pearl S. Tourette syndrome research Journal of Child Neurology. 21: 629. DOI: 10.1177/08830738060210081401  0.222
2018 Bhakta S, Talledo J, Alvarez A, Rana B, Swerdlow N. T219. Effects of Tolcapone on Sensorimotor Gating in Healthy Adults Biological Psychiatry. 83: S213. DOI: 10.1016/j.biopsych.2018.02.556  0.222
2000 Cadenhead K, Shafer K, Light G, Perry W, Geyer M, Swerdlow N, Brenner C, McDowell J, Granholm E, Paulus M, Braff D. 117. Vulnerability markers in schizotypal personality disorder: defining a phenotype Biological Psychiatry. 47: S35-S36. DOI: 10.1016/S0006-3223(00)00379-6  0.218
2011 Swerdlow NR. Are we studying and treating schizophrenia correctly? | Estamos estudiando y tratando correctamente la esquizofrenia? Psiquiatria Biologica. 18: 168-178. DOI: 10.1016/j.psiq.2011.10.010  0.215
2021 Clayson PE, Molina JL, Joshi YB, Thomas ML, Sprock J, Nungaray J, Swerdlow NR, Light GA. Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia. Psychiatry Research. 305: 114239. PMID 34673326 DOI: 10.1016/j.psychres.2021.114239  0.214
2023 Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, ... ... Swerdlow NR, et al. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. The American Journal of Psychiatry. appiajp20220649. PMID 37038743 DOI: 10.1176/appi.ajp.20220649  0.212
2021 Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, ... ... Swerdlow NR, et al. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. The American Journal of Psychiatry. appiajp202020081212. PMID 33985348 DOI: 10.1176/appi.ajp.2020.20081212  0.21
1988 Weinger MB, Swerdlow NR, Millar WL. Acute postoperative delirium and extrapyramidal signs in a previously healthy parturient. Anesthesia and Analgesia. 67: 291-5. PMID 3344981 DOI: 10.1213/00000539-198803000-00017  0.21
2019 Light GA, Swerdlow NR. Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31506611 DOI: 10.1038/S41386-019-0519-0  0.21
2023 Joshi Y, Swerdlow N, Light G. Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh. The American Journal of Psychiatry. 180: 841-842. PMID 37908092 DOI: 10.1176/appi.ajp.20230419r  0.21
1996 Farber R, Clementz B, Lam M, Swerdlow N. Predictive and visually-guided saccades in obsessive-compulsive disorder Biological Psychiatry. 39: 573. DOI: 10.1016/0006-3223(96)84197-7  0.209
1999 Doan QT, Swerdlow NR. Preliminary findings with a new Vietnamese Stroop test. Perceptual and Motor Skills. 89: 173-82. PMID 10544412 DOI: 10.2466/pms.1999.89.1.173  0.206
2018 Greenwood T, Downs N, Swerdlow N, Ferreira V. F117. Early Detection and Intervention for Mood Disorders: A Pilot Study Biological Psychiatry. 83: S283. DOI: 10.1016/J.Biopsych.2018.02.730  0.206
2022 Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, ... ... Swerdlow NR, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. PMID 35396580 DOI: 10.1038/s41586-022-04434-5  0.205
1999 Feifel D, Moutier CY, Swerdlow NR. Attitudes toward psychiatry as a prospective career among students entering medical school. The American Journal of Psychiatry. 156: 1397-402. PMID 10484951 DOI: 10.1176/Ajp.156.9.1397  0.205
2021 Molina JL, Joshi YB, Nungaray JA, Thomas ML, Sprock J, Clayson PE, Sanchez VA, Attarha M, Biagianti B, Swerdlow NR, Light GA. Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training. Schizophrenia Research. 236: 135-141. PMID 34500174 DOI: 10.1016/j.schres.2021.07.033  0.201
2021 Thomas ML, Duffy JR, Swerdlow N, Light GA, Brown GG. Detecting the Inverted-U in fMRI Studies of Schizophrenia: A Comparison of Three Analysis Methods. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 33949299 DOI: 10.1017/S1355617721000424  0.197
2022 Cavanagh JF, Olguin SL, Talledo JA, Kotz JE, Roberts BZ, Nungaray JA, Sprock J, Gregg D, Bhakta SG, Light GA, Swerdlow NR, Young JW, Brigman JL. Amphetamine alters an EEG marker of reward processing in humans and mice. Psychopharmacology. PMID 35132440 DOI: 10.1007/s00213-022-06082-z  0.197
2016 Downs NS, Alderman T, Schneiber K, Swerdlow NR. Treat and Teach Our Students Well: College Mental Health and Collaborative Campus Communities. Psychiatric Services (Washington, D.C.). appips201500465. PMID 27181737 DOI: 10.1176/appi.ps.201500465  0.194
2020 Molina JL, Thomas ML, Joshi YB, Hochberger WC, Koshiyama D, Nungaray JA, Cardoso L, Sprock J, Braff DL, Swerdlow NR, Light GA. Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia. Translational Psychiatry. 10: 405. PMID 33230190 DOI: 10.1038/s41398-020-01089-6  0.194
2006 Judd LL, Kuczenski R, Schuckit M, Swerdlow N. In memorium: Professor David S Segal Neuropsychopharmacology. 31: 2331. DOI: 10.1038/Sj.Npp.1301158  0.192
1999 Swerdlow NR. Tourette syndrome: Lessons from a model Cns Spectrums. 4: 16-17. DOI: 10.1017/S1092852900000778  0.19
2016 Swerdlow CD, Blumenthal T, Swerdlow NR. Reawakening Research on Reducing Shock Pain. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 26795457 DOI: 10.1016/J.Hrthm.2016.01.017  0.189
2024 Molina JL, Joshi YB, Nungaray JA, Sprock J, Attarha M, Biagianti B, Thomas ML, Swerdlow NR, Light GA. Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia. Psychological Medicine. 1-8. PMID 38587021 DOI: 10.1017/S0033291724000783  0.188
2001 Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, ... ... Swerdlow N, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204  0.187
2005 Swerdlow NR. Tourette syndrome: current controversies and the battlefield landscape. Current Neurology and Neuroscience Reports. 5: 329-31. PMID 16131414 DOI: 10.1007/S11910-005-0054-8  0.183
2022 Bhakta SG, Cavanagh JF, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Brigman JL, Light GA, Swerdlow NR, Young JW. EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35042948 DOI: 10.1038/s41386-021-01257-2  0.177
2002 Swerdlow NR, Shoemaker JM, Pitcher L, Platten A, Kuczenski R, Eleey CC, Auerbach P. Genetic differences in startle gating-disruptive effects of apomorphine: Evidence for central mediation Behavioral Neuroscience. 116: 682-690. DOI: 10.1037/0735-7044.116.4.682  0.171
2001 Swerdlow NR, Eastvold A, Uyan KM, Ploum Y, Cadenhead K. Matching strategies for drug studies of prepulse inhibition in humans. Behavioural Pharmacology. 12: 45-52. PMID 11270511  0.163
2024 Heathcote SD, Blumenthal TD, Swerdlow NR. Prepulse inhibition and the call alert in emergency medical services. Psychophysiology. e14508. PMID 38164815 DOI: 10.1111/psyp.14508  0.161
2023 Powell SB, Swerdlow NR. The Relevance of Animal Models of Social Isolation and Social Motivation for Understanding Schizophrenia: Review and Future Directions. Schizophrenia Bulletin. PMID 37527471 DOI: 10.1093/schbul/sbad098  0.154
2023 Joshi YB, Gonzalez CE, Molina JL, MacDonald LR, Min Din J, Minhas J, Leposke T, Nordberg B, Li F, Talledo J, Sprock J, Swerdlow NR, Light GA. Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders. Psychiatry Research. 327: 115215. PMID 37406367 DOI: 10.1016/j.psychres.2023.115215  0.145
2006 Swerdlow NR, Sutherland AN. Preclinical models relevant to Tourette syndrome. Advances in Neurology. 99: 69-88. PMID 16536353  0.142
2022 Swerdlow NR, Joshi YB, Sprock J, Talledo J, Molina JL, Delano-Wood L, Iwanaga D, Kotz JE, Huege S, Leger G, Light GA. Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36404550 DOI: 10.3233/JAD-220769  0.138
2021 Swerdlow NR, Kotz JE, Joshi YB, Talledo J, Sprock J, Molina JL, Huisa B, Huege SF, Romero JA, Walsh MJ, Delano-Wood L, Light GA. Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration. Journal of Alzheimer's Disease : Jad. PMID 34690144 DOI: 10.3233/JAD-215029  0.135
2024 Noback M, Bhakta SG, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Light GA, Swerdlow NR, Brigman JL, Cavanagh JF, Young JW. Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker. Cognitive, Affective & Behavioral Neuroscience. PMID 38168850 DOI: 10.3758/s13415-023-01150-z  0.13
1994 Swerdlow N, Britton K. Alphaxalone inhibits CRF- but not strychnine-potentiated acoustic startle Biological Psychiatry. 35: 630-631. DOI: 10.1016/0006-3223(94)90715-3  0.124
1993 Swerdlow NR. Dopamine and depression: circuitous logic? Biological Psychiatry. 33: 757-8. PMID 8353174 DOI: 10.1016/0006-3223(93)90130-6  0.124
2024 Light GA, Swerdlow NR. Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers? The American Journal of Psychiatry. 181: 272-274. PMID 38557145 DOI: 10.1176/appi.ajp.20240100  0.12
2021 Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Translational Psychiatry. 11: 482. PMID 34535625 DOI: 10.1038/s41398-021-01562-w  0.119
1996 Clementz BA, Farber RH, Lam MN, Swerdlow NR. Ocular motor responses to unpredictable and predictable smooth pursuit stimuli among patients with obsessive-compulsive disorder. Journal of Psychiatry & Neuroscience : Jpn. 21: 21-8. PMID 8580114  0.118
2010 Swerdlow NR. Prepulse Inhibition of Startle in Humans and Laboratory Models Encyclopedia of Neuroscience. 947-955. DOI: 10.1016/B978-008045046-9.01938-0  0.094
2023 Swerdlow NR, Gonzalez CE, Raza MU, Gautam D, Miyakoshi M, Clayson PE, Joshi YB, Molina JL, Talledo J, Thomas ML, Light GA, Sivarao DV. Effects of memantine on the auditory steady state and harmonic responses to 40 Hz stimulation across species. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 37683728 DOI: 10.1016/j.bpsc.2023.08.009  0.086
1988 Ruegg RG, Zisook S, Swerdlow NR. Depression in the aged. An overview. The Psychiatric Clinics of North America. 11: 83-99. PMID 3288982  0.062
2022 Cavanagh JF, Gregg D, Light GA, Olguin SL, Sharp RF, Bismark AW, Bhakta SG, Swerdlow NR, Brigman JL, Young JW. Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. Translational Psychiatry. 12: 290. PMID 35864090 DOI: 10.1038/s41398-022-02070-1  0.061
1989 Swerdlow NR, Andia AM. Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder. The American Journal of Psychiatry. 146: 1637. PMID 2589561  0.059
1998 Swerdlow N. 259. Converging paths towards a neurobiology of OCD, TS and beyond Biological Psychiatry. 43: S78. DOI: 10.1016/S0006-3223(98)90707-7  0.051
1998 Swerdlow NR. Startle in Tourette's syndrome. Biological Psychiatry. 44: 935-6. PMID 9807655 DOI: 10.1016/S0006-3223(98)00066-3  0.049
1994 Clementz B, Lam M, Swerdlow N. Smooth pursuit and predictive saccadic tracking in patients with OCD Biological Psychiatry. 35: 674. DOI: 10.1016/0006-3223(94)90870-2  0.047
1990 Swerdlow NR, Gierz M, Berkowitz A, Nemiroff R, Lohr J. Electroconvulsive therapy in a patient with severe tic and major depressive episode. The Journal of Clinical Psychiatry. 51: 34-5. PMID 2295590  0.039
1992 Swerdlow NR. Animal Models in Psychiatry, I. Neuromethods, Volume 18.Alan A. Boulton , Glen B. Baker , Mathew T. Martin-IversonAnimal Models in Psychiatry, II. Neuromethods, Volume 19.Alan A. Boulton , Glen B. Baker , Mathew T. Martin-Iverson The Quarterly Review of Biology. 67: 405-405. DOI: 10.1086/417759  0.039
2001 Swerdlow NR, Young AB. Neuropathology in Tourette syndrome: an update. Advances in Neurology. 85: 151-61. PMID 11530425  0.034
1990 Koob GF, Cole BJ, Swerdlow NR, Le Moal M, Britton KT. Stress, performance, and arousal: focus on CRF. Nida Research Monograph. 97: 163-76. PMID 2174122  0.022
2010 Swerdlow NR. Preface Current Topics in Behavioral Neurosciences. 4: v-vii. DOI: 10.1007/978-3-642-13717-4  0.01
1993 Pardee D, Swerdlow N. Not the earliest solar eclipse Nature. 363: 406-406. DOI: 10.1038/363406B0  0.01
Hide low-probability matches.